Metrochem API Private Limited Metrochem API Private Limited

X

Find the latest news about Promontory Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Promontory Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1350 Avenue of the Americas 23rd Floor New York, NY 10019
Telephone
Telephone
(646) 380-2441

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/promontory-therapeutics-completes-enrollment-of-phase-2-trial-of-pt-112-in-late-line-patients-with-metastatic-castration-resistant-prostate-cancer-302083644.html

PR NEWSWIRE
08 Mar 2024

https://www.prnewswire.com/news-releases/promontory-therapeutics-to-present-data-on-pt-112-mechanism-of-action-at-the-society-for-immunotherapy-of-cancers-38th-annual-meeting-301968314.html

PR NEWSWIRE
26 Oct 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-presents-data-on-the-molecular-effects-of-pt-112-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-301956747.html

PR NEWSWIRE
14 Oct 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-early-phase-2-clinical-trial-data-from-the-national-cancer-institute-demonstrating-pt-112s-immune-activation-in-thymic-epithelial-tumors-301947973.html

PR NEWSWIRE
05 Oct 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-to-present-molecular-effects-of-pt-112-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-301946624.html

PR NEWSWIRE
04 Oct 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-selected-as-the-first-international-biotech-company-member-of-the-paris-saclay-cancer-cluster-301942569.html

PR NEWSWIRE
29 Sep 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-expands-phase-2-trial-of-pt-112-in-metastatic-castrate-resistant-prostate-cancer-to-france-301881237.html

PR NEWSWIRE
20 Jul 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-preliminary-data-from-the-national-cancer-institute-phase-2-clinical-trial-of-pt-112-in-thymoma-and-thymic-carcinoma-at-2023-asco-annual-meeting-301841509.html

PR NEWSWIRE
02 Jun 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-to-participate-in-business-development-strategies-panel-at-the-sachs-9th-annual-immuno-oncology-innovation-forum-301839068.html

PR NEWSWIRE
31 May 2023

https://www.prnewswire.com/news-releases/promontory-therapeutics-to-present-clinical-trial-for-pt-112-in-prostate-cancer-at-the-asco-2023-genitourinary-cancers-symposium-301736829.html

PR NEWSWIRE
02 Feb 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY